Premier Perspectives The blog for insider insights in clinical development Clinical Research: Phase 1 - Phase 4 5 Key Takeaways: Drug and Device Development Secrets in the World of Medical Aesthetics By Nach Davé May 27, 2021 Featured Posts Learn more about the latest events and updates. Study Design Compensating for the Unknown: 3 Keys to Implementing a Successful Decentralized Clinical Trial By Nach Davé May 13, 2021 Consulting Entering a New Clinical Phase of Non-Traditional Data Sources By Nach Davé September 30, 2020 Recent Posts Learn more about the latest events and updates. By expertise area All expertise areas AnalgesiaDermatologyMedical DeviceNeuroscienceOncology & HematologyPediatricsRare DiseaseOtherCOVID-19Cell & Gene Therapy By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualitySafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting Can Your Clinical Data Strategy Keep Pace? By Nach Davé September 3, 2020 Data Management & Biostatistics Real-World Data and Real-World Evidence: What Is Their Value as a Synthetic Control Arm? By Nach Davé May 26, 2020 COVID-19 Data Driven: How Electronic Patient-Reported Outcomes (ePROs) Provide a Vital Opportunity to Capture Key Data Beyond the COVID-19 Crisis By Nach Davé April 30, 2020 COVID-19 What Is FDA’s Emergency Use Authorization (EUA) and How Can It Help Develop Therapies Faster? By Nach Davé March 20, 2020 COVID-19 FDA Issues Guidance on Clinical Trials During COVID-19 By Nach Davé March 20, 2020 Global Compliance Strategic Planning for Compliance With the EU Medical Device Regulation By Nach Davé June 12, 2019 1 2 Next × ALSO OF INTERESTPremier Research Names Nach Davé VP of Global...PharmaVoice – Small Pharma Driving Big Pharma...Are We Trading Speed for Innovation in...
